tradmap

BCPC Financials Balchem Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 8.1% per year over the past 5 years.
  • Net income has grown faster than revenue (12.8% vs 8.1% per year).
  • Operating margin has expanded, at 20.2% in the latest year.
  • Free cash flow has grown 1.5% per year over the past 5 years.

Shareholder returns

  • Dividends have been paid for 12 consecutive years, consuming 18.3% of earnings.
  • The dividend has grown 11.1% per year over the past 5 years.
Revenue & net income
$0 $519M $1B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 18% 36% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 8% 17% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
$0 $62M $124M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $149M $298M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$416M -$85M $247M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $1.0B $155M 35.7% 20.2% 12.3% 9.2% — — $75M
2024 $954M $128M 35.3% 19.2% 11.2% 8.2% — — $50M
2023 $922M $109M 32.7% 17.3% 10.3% 6.8% — — $64M
2022 $942M $105M 29.8% 15.4% 11.2% 6.5% $89M — $67M
2021 $799M $96M 30.4% 16.0% 11.0% 8.0% $124M — $103M
2020 $704M $85M 31.8% 15.8% 10.2% 7.3% $118M — $85M
2019 $644M $80M 32.8% 15.9% 10.7% 6.9% $99M — $66M
2018 $644M $79M 31.7% 16.6% 11.4% 8.0% $100M $156M $54M
2017 $595M $90M 31.8% 16.3% 14.6% 9.3% $83M $219M $40M
2016 $553M $56M 32.7% 16.4% 10.7% 5.9% $85M $261M $39M
2015 — $60M — — 12.9% 6.8% $63M $261M $85M
2014 — $53M — — 13.5% 6.1% — $298M $50M
2013 — $45M — — 13.5% 11.9% $48M $0 $209M
2012 — $40M — — 14.7% 12.8% $40M $0 $145M
2011 — $39M — — 16.7% 14.3% $38M $1M $115M

Valuation over time

How the market has priced BCPC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 26.4 52.8 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 3.1 6.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 0.3 0.6 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is BCPC growing its revenue and profit?

Over the past 5 years, Balchem Corp's revenue has grown 8.1% per year, and net income grown 12.8% per year. These are computed facts, not advice.

How much debt does BCPC have?

As of FY2025, Balchem Corp reported — of total debt against $75M of cash.

What is BCPC's profit margin?

In FY2025, gross margin was 35.7%, operating margin 20.2%, and net margin 14.9%.

What is BCPC's P/E ratio?

Balchem Corp's P/E (TTM) is 32.67 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the BCPC stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 36.0× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.